Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Jul 1;22(1):174.
doi: 10.1186/s12911-022-01915-5.

Using an optimized generative model to infer the progression of complications in type 2 diabetes patients

Affiliations

Using an optimized generative model to infer the progression of complications in type 2 diabetes patients

Xiaoxia Wang et al. BMC Med Inform Decis Mak. .

Abstract

Background: People live a long time in pre-diabetes/early diabetes without a formal diagnosis or management. Heterogeneity of progression coupled with deficiencies in electronic health records related to incomplete data, discrete events, and irregular event intervals make identification of pre-diabetes and critical points of diabetes progression challenging.

Methods: We utilized longitudinal electronic health records of 9298 patients with type 2 diabetes or prediabetes from 2005 to 2016 from a large regional healthcare delivery network in China. We optimized a generative Markov-Bayesian-based model to generate 5000 synthetic illness trajectories. The synthetic data were manually reviewed by endocrinologists.

Results: We build an optimized generative progression model for type 2 diabetes using anchor information to reduce the number of parameters learning in the third layer of the model from [Formula: see text] to [Formula: see text], where [Formula: see text] is the number of clinical findings, [Formula: see text] is the number of complications, [Formula: see text] is the number of anchors. Based on this model, we infer the relationships between progression stages, the onset of complication categories, and the associated diagnoses during the whole progression of type 2 diabetes using electronic health records.

Discussion: Our findings indicate that 55.3% of single complications and 31.8% of complication patterns could be predicted early and managed appropriately to potentially delay (as it is a progressive disease) or prevented (by lifestyle modifications that keep patient from developing/triggering diabetes in the first place).

Conclusions: The full type 2 diabetes patient trajectories generated by the chronic disease progression model can counter a lack of real-world evidence of desired longitudinal timeframe while facilitating population health management.

Keywords: Computer simulation; Diabetes mellitus, type 2; Disease progression model; Electronic health records; Probabilistic generative model.

PubMed Disclaimer

Conflict of interest statement

JP reports receiving personal fees from Summary Medical Inc and DispatchHealth and equity from Summary Medical Inc outside the submitted work. DB reports receiving grants and personal fees from EarlySense, personal fees from CDI Negev, equity from Valera Health, equity from CLEW Medical, equity from MDClone, personal fees and equity from AESOP, personal fees and equity from FeelBetter, and grants from IBM Watson Health, outside the submitted work.

Figures

Fig. 1
Fig. 1
The outline of Wang et al.’s model, where K is the number of disease stages, M is the number of complications, and N is the number ICD codes
Fig. 2
Fig. 2
An illustration of before and after optimizing the observable bottom layer
Fig. 3
Fig. 3
A Comparison of complications of 5000 virtual patients learned by our optimized model (a) as well as two representative patients retrieved by our medical experts (bc). Note that for (a), we first use 35,210 encounters with 64,383 positive observations to learn our generative model. We next use this learned generative model to generate 5000 (that is a specified number) synthetic patient trajectories. Thus, 8.5, 13.0 19.3, 23.9, etc., were the mean progression years at stages I to V, respectively

References

    1. Prediabetes—your chance to prevent type II diabetes. US Centers for Disease Control and Prevention. 11 June 2020. https://www.cdc.gov/diabetes/basics/prediabetes.html#:~:text=Approximate.... Accessed Aug 2020.
    1. Wang L, Gao P, Zhang M, Zhang D, et al. Prevalence and ethnic pattern of diabetes and prediabetes in China in 2013. J Am Med Assoc. 2017;317(24):2515–2523. doi: 10.1001/jama.2017.7596. - DOI - PMC - PubMed
    1. Fonseca VA. Defining and characterizing the progression of type II diabetes. Diabetes Care. 2009;32(suppl 2):S151–S156. doi: 10.2337/dc09-S301. - DOI - PMC - PubMed
    1. Colagiuri S. Epidemiology of prediabetes. Med Clin N Am. 2011;95(2):299–307. doi: 10.1016/j.mcna.2010.11.003. - DOI - PubMed
    1. Rooney MR, Rawlings AM, Pankow JS, et al. Risk of progression to diabetes among older adults with prediabetes. JAMA Intern Med. 2021;181(4):511–519. doi: 10.1001/jamainternmed.2020.8774. - DOI - PMC - PubMed

Publication types

MeSH terms